The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Induction of Sustained Hypercholesterolemia by Single Adeno-Associated Virus–Mediated Gene Transfer of Mutant hPCSK9
Abstract
Objectives—: Patients with mutations in the proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) gene have hypercholesterolemia and are at high risk of adverse cardiovascular events. We aimed to stably express the pathological human D374Y gain-of-function mutant form of PCSK9 ( PCSK9 DY ) in adult wild-type mice to generate a hyperlipidemic and proatherogenic animal model, achieved with a single systemic injection with adeno-associated virus (AAV). Approach and Results—: We constructed an AAV-based vector to support targeted transfer of the PCSK9 DY gene to liver. After injection with 3.5×10 10 viral particles, mice in the C57BL/6J, 129/SvPasCrlf, or FVB/NCrl backgrounds developed long-term hyperlipidemia with a strong increase in serum low-density lipoprotein. Macroscopic and histological analysis showed atherosclerotic lesions in the aortas of AAV- PCSK9 DY mice fed a high-fat-diet. Advanced lesions in these high-fat-diet–fed mice also showed evidence of macrophage infiltration and fibrous cap formation. Hepatic AAV- PCSK9 DY infection did not result in liver damage or signs of immunologic response. We further tested the use of AAV- PCSK9 DY to study potential genetic interaction with the ApoE gene. Histological analysis of ApoE −/− AAV- PCSK9 DY mice showed a synergistic response to ApoE deficiency, with aortic lesions twice as extensive in ApoE −/− AAV- PCSK9 DY -transexpressing mice as in ApoE −/− AAV- Luc controls without altering serum cholesterol levels. Conclusions—: Single intravenous AAV- PCSK9 DY injection is a fast, easy, and cost-effective approach, resulting in rapid and long-term sustained hyperlipidemia and atherosclerosis. We demonstrate as a proof of concept the synergy between PCSK9 DY gain-of-function and ApoE deficiency. This methodology could allow testing of the genetic interaction of several mutations without the need for complex and time-consuming backcrosses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Manno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J. E., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1358 · Cited by 2,163
Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice
Lagace, T. A., Curtis, D. E., Garuti, R., McNutt, M. C., Park, S. W., Prather, H. B., Anderson, N. N., Ho, Y. K., Hammer, R. E., & Horton, J. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29383 · Cited by 681
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
Stein, E. A., Mellis, S., Yancopoulos, G. D., Stahl, N., Logan, D., Smith, W. B., Lisbon, E., Gutierrez, M., Webb, C., Wu, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105803 · Cited by 664
Poirier, S., Mayer, G., Benjannet, S., Bergeron, E., Marcinkiewicz, J., Nassoury, N., Mayer, H., Nimpf, J., Prat, A., & Seidah, N. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708098200 · Cited by 477
Ishibashi, S., Herz, J., Maeda, N., Goldstein, J. L., & Brown, M. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4431 · Cited by 430
Zsebo, K., Yaroshinsky, A., Rudy, J. J., Wagner, K., Greenberg, B., Jessup, M., & Hajjar, R. J. (2014) · Circulation Research · doi:10.1161/circresaha.113.302421 · Cited by 315
Frykman, P. K., Brown, M. S., Yamamoto, T., Goldstein, J. L., & Herz, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8453 · Cited by 256
TANG, Z., JIANG, L., PENG, J., REN, Z., WEI, D., WU, C., PAN, L., JIANG, Z., & LIU, L. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1072 · Cited by 208
Targeting PCSK9 for hypercholesterolemia
Norata, G. D., Tibolla, G., & Catapano, A. L. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-140025 · Cited by 127
Research works printed but not linked: 37
- 10.1038/nrcardio.2011.158 · DOI
- 10.1016/B978-0-12-394596-9.00001-9 · DOI
- 10.1016/j.cell.2011.04.005 · DOI · Paper page
- 10.1016/S0092-8674(01)00238-0 · DOI · Paper page
- 10.1172/JCI116663 · DOI · Paper page
- 10.1042/BJ20070664 · DOI
- 10.1194/jlr.M900273-JLR200 · DOI · Paper page
- 10.1111/j.0009-9163.2004.0238.x · DOI · Paper page
- 10.1007/s11883-012-0300-x · DOI
- 10.1161/circulationaha.111.057406 · DOI · Paper page
- 10.1073/pnas.0402133101 · DOI · Paper page
- 10.1016/j.atherosclerosis.2012.04.006 · DOI
- 10.1007/s00439-003-1071-9 · DOI · Paper page
- 10.1038/nsmb1235 · DOI · Paper page
- 10.1016/B978-0-12-386509-0.00012-0 · DOI · Paper page
- 10.1038/mt.2013.285 · DOI
- 10.1093/cvr/cvs218 · DOI · Paper page
- 10.1111/1753-0407.12064 · DOI
- 10.1016/j.atherosclerosis.2008.10.027 · DOI
- 10.1161/atvbaha.110.204040 · DOI
- 10.1038/ng1161 · DOI · Paper page
- 10.1126/scitranslmed.3004853 · DOI · Paper page
- 10.1016/j.atherosclerosis.2009.02.012 · DOI
- 10.1006/mthe.2000.0075 · DOI · Paper page
- 10.1161/01.ATV.19.8.1960 · DOI · Paper page
- 10.1161/01.ATV.14.9.1480 · DOI · Paper page
- 10.1016/0021-9150(95)05602-S · DOI
- 10.1002/hep.22354 · DOI · Paper page
- 10.1172/JCI117179 · DOI · Paper page
- 10.1038/mt.2012.119 · DOI
- 10.1515/BC.1999.078 · DOI
- 10.1016/j.bbrc.2008.07.106 · DOI · Paper page
- 10.1161/hq0901.095147 · DOI · Paper page
- 10.1016/S0022-2275(20)32367-1 · DOI
- 10.1016/j.atherosclerosis.2011.04.018 · DOI
- 10.1016/j.atherosclerosis.2013.01.044 · DOI
- 10.1016/S0140-6736(12)60771-5 · DOI · Paper page
Cited by
Macrophages in Atherosclerosis Regression
Barrett, T. J. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312802 · Cited by 628
Animal models of atherosclerosis
Emini Veseli, B., Perrotta, P., De Meyer, G. R. A., Roth, L., Van der Donckt, C., Martinet, W., & De Meyer, G. R. Y. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.010 · Cited by 548
Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity
Frismantiene, A., Philippova, M., Erne, P., & Resink, T. J. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.08.019 · Cited by 406
Sex as a Biological Variable in Atherosclerosis
Man, J. J., Beckman, J. A., & Jaffe, I. Z. (2020) · Circulation Research · doi:10.1161/circresaha.120.315930 · Cited by 402
Daugherty, A., Tall, A. R., Daemen, M. J. A. P., Falk, E., Fisher, E. A., García-Cardeña, G., Lusis, A. J., Owens, A. P., Rosenfeld, M. E., & Virmani, R. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atv.0000000000000062 · Cited by 316
Metadata
- Authors
- Roche-Molina, M., Sanz-Rosa, D., Cruz, F. M., García-Prieto, J., López, S., Abia, R., Muriana, F. J. G., Fuster, V., Ibáñez, B., & Bernal, J. A.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2015-01
- Volume
- 35
- Issue
- 1
- Pages
- 50-59
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2044729056
- Cited by
- 183
- References
- 12
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Induction of Sustained Hypercholesterolemia by Single Adeno-Associated Virus–Mediated Gene Transfer of Mutant hPCSK9. https://app.cochat.ai/papers/10.1161/atvbaha.114.303617
- The paper
- Roche-Molina, M., Sanz-Rosa, D., Cruz, F. M., García-Prieto, J., López, S., Abia, R., Muriana, F. J. G., Fuster, V., Ibáñez, B., & Bernal, J. A. (2015). Induction of Sustained Hypercholesterolemia by Single Adeno-Associated Virus–Mediated Gene Transfer of Mutant hPCSK9. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.114.303617
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.